Ad hoc reviewer for scientific journals
● Acta Histochemica
● Anatomical Record
● Alternatives to Animal Experimentation
● Alternatives to Laboratory Animals
● Anti-Cancer Drugs
● Applied In Vitro Toxicology
● Archives of Biochemistry and Biophysics
● Archives of Toxicology
● Biochimica et Biophysica Acta Biomembranes
● Biochimica et Biophysica Acta Molecular Basis of Disease
● Biochimica et Biophysica Acta Molecular Cell Research
● BioMed Research International
● Biomedicine and Pharmacotherapy
● Biotechnic and Histochemistry
● Biotechnology and Bioengineering
● BMC Cancer
● BMC Cell Biology
● Cardiovascular Therapeutics
● Cell Biology and Toxicology
● Cell Death and Differentiation
● Cellular and Molecular Biology Letters
● Cellular and Molecular Immunology
● Chemical Research in Toxicology
● Chemico-Biological Interactions
● Clinical Science
● Computational Toxicology
● Critical Reviews in Toxicology
● Current Opinion in Toxicology
● Current Research in Pharmacology and Drug Discovery
● Current Research in Toxicology
● Disease Markers
● Drug Discovery Today
● Environmental Health Perspectives
● Environmental Science and Technology
● Environmental Toxicology and Pharmacology
● European Journal of Cell Biology
● European Journal of Histochemistry
● European Medical Journal
● Experimental Dermatology
● Experimental and Molecular Pathology
● FEBS Letters
● Food and Chemical Toxicology
● Frontiers in Cellular Neuroscience
● Frontiers in Chemistry
● Frontiers in Membrane Physiology and Membrane Biophysics
● Future Oncology
● Future Virology
● International Journal of Biomedical Science
● International Journal of Developmental Neuroscience
● International Journal of Molecular Sciences
● In Vitro Cellular and Developmental Biology Animal
● Journal of Biological Chemistry
● Journal of Cellular and Molecular Medicine
● Journal of Clinical Investigation
● Journal of Controlled Release
● Journal of Experimental and Clinical Cancer Research
● Journal of Hepatology
● Journal of Immunological Methods
● Journal of Pediatric Biochemistry
● Journal of Pharmacological and Toxicological Methods
● Journal of Physiology
● Life Sciences
● Liver International
● Methods in Molecular Biology
● Molecular Neurobiology
● Nature Reviews on Cancer
● Nephrology Dialysis Transplantation
● NPJ Microgravity
● Pharmacometrics and Systems Pharmacology
● PLoS One
● Progress in Neuropsychopharmacology and Biological Psychiatry
● Regulatory Toxicology and Pharmacology
● Science Advances
● Science Translational Medicine
● Scientific Reports
● Stem Cells Translational Medicine
● Toxicologic Pathology
● Toxicological Sciences
● Toxicology In Vitro
● Toxicology Letters
● Toxicology Mechanisms and Methods
● Toxicology Research
● World Journal of Gastroenterology
● World Journal of Gastrointestinal Pathophysiology
● World Journal of Hepatology
Reviewer of grant applications submitted to Belgian agencies
Federal Public Service Public Health, Food Chain Safety and Environment of Belgium (2020)
Fonds De La Recherche Scientifique (2010, 2013 and 2022)
Institute for Innovation by Science and Technology (2007 and 2008)
Member of the Research Foundation Flanders (FWO) Expert Panel on Gastroenterology, Hepatology, Endocrinology, Metabolism and Nutrition, Reproduction, Urogenital System (2020-2022)
Reviewer of grant applications submitted to non-Belgian agencies
Alternatives Research and Development Foundation-USA (2019)
Association for International Cancer Research-United Kingdom (2010)
Auckland Medical Research Foundation-New Zealand (2017, 2019, 2021 and 2023)
Austrian Science Fund (2020)
Banting Postdoctoral Fellowship Program of the Government of Canada-Canada (2018)
La Caixa Foundation-Spain (2021)
Chief Scientist Office-United Kingdom (2013-2014)
Croatian Science Foundation (2023)
Czech Science Foundation and the Czech Health Research Council -Czech Republic (2015-2018)
European Cooperation in Science and Technology (COST) (2019)
FP7 European project RBUCE-UP (2012)
French National Research Agency-France (2016)
Innovative Systems Toxicology for Alternatives to Animal Testing, a joint initiative between Netherlands Organisation for Health Research and Development (ZonMw), the German Federal Ministry of Education and Research (BMBF) and the Belgian National Fund for Scientific Research (FNRS) (2015-2023)
Israeli Ministry of Innovation, Science and Technology (2023)
Johns Hopkins University Center for Alternatives to Animal Testing (2020)
Medical Research Council-United Kingdom (2010, 2012, 2014, 2016, 2017 and 2018)
NC3Rs-United Kingdom (2012, 2014, 2018, 2019, 2020 and 2021)
Netherlands Organisation of Scientific Research-The Netherlands (2014)
Starting Grant program European Research Council (2017)
Swedish Research Council for Sustainable Development (2022)
Swiss 3R Competence Center-Switzerland (2019)
Swiss National Science Foundation (2023)
The British Skin Foundation-United Kingdom (2011)
University of Padova-Italy (2011)
DOCTORAL THESIS JURIES
Member of doctoral thesis juries at Vrije Universiteit Brussel-Belgium
Schallier A.; “Discovery of glutamate transporters as novel drug targets for epilepsy and Alzheimer’s disease” (2011); Promoters: Prof. Dr. I. Smolders and Dr. A. Massie; Co-promoter: Prof. Dr. Y. Michotte.
Alaerts G.; “Chromatographic fingerprints of herbal extracts as tools for identification or quality control” (2012); Promoters: Prof. Dr. Y. Vander Heyden and Prof. Dr. J. Smeyers-Verbeke; Co-promoter: Dr. B. Dejaegher.
De Geyter D.; “The effects of systemic administration of the insulin-like growth factor-I in a rat model for ischemic stroke” (2012); Promoter: Prof. Dr. R. Kooijman; Co-promoter: Prof. Dr. J. De Keyser.
Guimarães E.; “Investigation of mechanisms in hepatic stellate cell activation in vitro” (2012); Promoter: Prof. Dr. L. van Grunsven.
Loyens E.; “The role of insulin-regulated aminopeptidase and its substrates in mechanisms of epilepsy and antidepressant-like activity” (2012); Promoter: Prof. Dr. I. Smolders; Co-promoters: Prof. Dr. Y. Michotte and Prof. Dr. P. Vanderheyden.
Vermoesen K..; “Evaluation of the convulsant liability and antiepileptic properties of antidepressant” (2012); Promoter: Prof. Dr. R. Clinckers; Co-promoters: Prof. Dr. I. Smolders and Prof. Dr. A. Massie.
Van Haute L.; “Human embryonic stem cells as a paradigm for disease modelling in respiration” (2013); Promoter: Prof. Dr. K. Sermon; Co-promoter: Prof. Dr. M. De Rycke.
Schroyen B.; “The role of leptin, insulin and insulin-like growth factor binding protein 3 during hepatic stellate cell activation” (2014); Promoter: Prof. Dr. L. van Grunsven; Co-promoter: Prof. Dr. M. Nyssen.
Varçin M.; “Oxidative stress, PINK1 and neuroprotection in experimental models of Parkinson’s disease” (2014); Promoter: Prof. Dr. Y. Michotte; Co-promoter: Dr. S. Sarre.
Baert Y.; “In vitro systems to restore male fertility following testicular tissue banking” (2016); Promoter: Prof. Dr. E. Goossens.
Bentea E.; “Targeting the cystine/glutamate antiporter for neuroprotection: insights from mouse models of Parkinson’s disease” (2016); Promoter: Prof. Dr. A. Massie; Co-promoter: Prof. Dr. I. Smolders.
Buyl K.; “Characterization and reprogramming of umbilical cord-derived mesenchymal stromal cells towards the hepatic lineage” (2017); Promoters: Prof. Dr. J. De Kock, Prof. Dr. T. Vanhaecke and Prof. Dr. V. Rogiers.
Leclercq K.; “Development of preclinical models of treatment-resistant epilepsy for application in future antiepleptic drug discovery” (2017); Promoter: Prof. Dr. I. Smolders; Co-promoter: Dr. R. Kaminski.
Albertini G.; “Glial modulators of extracellular glutamate and their involvement in pathological behavior” (2018); Promoters: Prof. Dr. I. Smolders and Prof. Dr. A. Massie.
De Prins A.; “Development and biological evaluation of neuromedin U analogs as tools for functional elucidation: focus on stress-related disorders” (2018); Promotors: Prof. Dr. I. Smolders and Prof. Dr. S. Ballet; Co-promotors: Prof. Dr. A. Van Eeckhaut, Prof. Dr. D. De Bundel and Prof. Dr. V. Caveliers.
Laeremans T.; “The role of natural killer cells in functional cure strategies against human immunodeficiency virus type 1 infection” (2023); Promotors: Prof. Dr. J. Aerts and Prof. Dr. S. Allard; Co-promotor: Prof. Dr. G. Vanham.
Member of doctoral thesis juries at other Belgian universities
Wynant I.; “Heterologous expression systems for the production of metabolites during early drug research” (2010); Promoter: Prof. Dr. L. Droogmans; Co-promoters: Prof. Dr. J.-P. Simon and Dr. H. Bohets; Institut de Recherchers Microbiologiques, Université Libre de Bruxelles-Belgium.
Bol M.; “Modulation of the vascular function by cannabinoids, calcitonin gene related peptide and connexin hemichannels” (2013); Promoter: Prof. Dr. L. Leybaert; Co-promoter: Prof. Dr. B. Vanheel; Department of Basic Medical Sciences, Universiteit Gent-Belgium.
Oorts M.; “Understanding drug-induced cholestasis: mechanistic exploration of hepatic bile acid disposition” (2017); Promoter: Prof. Dr. P. Annaert; Co-promoter: Prof. Dr. L. Richert; Department of Pharmaceutical and Pharmacological Sciences, Katholieke Universiteit Leuven-Belgium.
Iyyathurai J.; “The regulation of Cx43-hemichannel function by intramolecular interactions via the SH3-binding domain and by autophagy” (2017); Promoter: Prof. Dr. G. Bultynck; Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven-Belgium.
Ramadan R.; “The role of intercellular communication in radiation-induced atherosclerosis” (2019); Promoter: Prof. Dr. L. Leybaert and Dr. A. Aerts; Department of Basic Medical Sciences, Universiteit Gent-Belgium.
Ghosh S.; “Use of iPSC-derived hepatocyte-like cells for hepatotoxicity testing” (2023); Promotor: Prof. Dr. M. C. Verfaillie; Department of Development and Regeneration Stem Cell Biology and Embryology, Katholieke Universiteit Leuven-Belgium; Co-promotor: Prof. Dr. M. T. D. Cronin; Liverpool John Moores University-United Kingdom.
Member of doctoral thesis juries at non-Belgian universities
Jetten M.; “Toxicogenomics responses in the in vitro liver: a view on human interindividual variation” (2014); Promoter: Prof. Dr. J.C.S. Kleinjans; Department of Toxicogenomics, Universiteit Maastricht-The Netherlands.
Gago Fuentes R.; “Role of the C-terminal tail of Cx43 in adult articular chondrocytes” (2016); Promoter: Prof. Dr. M.D. Mayan Santos and Prof. Dr. F.J. Blanco Garcia; Instituto de Investigación Biomédica, Universidade da Coruña-Spain.
Hiemstra S.; “High throughput microscopy of mechanism-based reporters of drug-induced liver injury” (2016); Promoter: Prof. Dr. B. van de Water; Leiden Academic Center for Drug Research, Universiteit Leiden-The Netherlands.
Vatakuti S.; “Toxicogenomics of precision-cut liver slices for prediction of human liver toxicity: a prevalidation study” (2016); Promoters: Prof. Dr. G.M.M. Groothuis and Prof. Dr. P. Olinga; Department of Pharmacy, Rijksuniversiteit Groningen-The Netherlands.
Jiang J.; “Mechanisms of drug induced liver injury: toxicogenomics studies in different in vitro models” (2017); Promoter: Prof. Dr. T. de Kok; Department of Toxicogenomics, Universiteit Maastricht-The Netherlands.
Hendriks D.; “Hepatic 3D spheroids as a model system for drug-induced liver injury and cytochrome P450 induction” (2018); Promoter: Prof. Dr. M. Ingelman-Sundberg; Co-promoters: Prof. Dr. I. Johansson and Prof. Dr. S. Mkrtchian; Department of Physiology and Pharmacology, Karolinska Institute-Sweden.
Wolters J.; “Toxicogenomics approaches in vitro for unraveling the mechanisms for hepatotoxicity” (2018); Promoter: Prof. Dr. J. Kleinjans; Department of Toxicogenomics, Universiteit Maastricht-The Netherlands.
Verheijen M.; “Transcriptomics close to my heart: advanced models and methods for toxicogenomics research illustrated by anthracycline-induced cardiotoxicity” (2019); Promoter: Prof. Dr. J. Kleinjans; Co-promotor: Prof. Dr. F. Caiment; Department of Toxicogenomics, Universiteit Maastricht-The Netherlands.
O'Donovan S.D.; “Modelling the dynamics in time-series of metabolomic and transcriptomic data” (2020); Promoters: Prof. T. de Kok, Prof. R. Peeters, Prof. N. van Riel and Prof. I. Arts; Department of Toxicogenomics, Universiteit Maastricht-The Netherlands.
Kasteel E.E.J.; “Next generation risk assessment of chemicals: in vitro and in silico approaches to work towards enough precision to make a decision” (2021); Promoter: Prof. Dr. J. Legler; Co-promoters: Dr. N. Kramer and Dr. R. Westerink; Faculty of Veterinary Sciences, Utrecht University-The Netherlands.
Wellens S.; “Differentiation of brain like endothelial cells from iPSC and application to BBB toxicity testing” (2021); Promoter: Prof. Dr. M. Culot; Université d’Artois-France.
Kralj T.; “Multi-omics characterisation of drug-induced liver injury in human-derived hepatocyte models” (2021); Promoters: Prof. Dr. D. Creek and Prof. Dr. K. Brouwer; Monash University-Australia.
Cox C.; “Evaluating the role of mitochondrial genetics in adverse-drug reactions and the application of iPSC-derived hepatocytes for modelling drug-induced liver injury” (2023); Dr. P. Sharma, Dr. A. Chadwick and Prof. Dr. C. Goldring; University of Liverpool-United Kingdom.
Rasool N.; “Pharmacological and toxicological evaluation of Argyrolobium Roseum (Camb.) Jaub and Spach extracts against lead induced hepato-renal toxicity in rodents" (2023); Prof. Dr. M. Ovais Omer; University of Veterinary and Animal Sciences-Pakistan.
Lavriha P.; “Molecular mechanisms of connexin-32 gating” (2023); Prof. Dr. V. Korkhoven, Prof. Dr. M. Pilhofer and Prof. Dr. M. Peter; Swiss Federal Institute of Technology-Switzerland.
Wang Z.; “Intrahepatic cholangiocyte organoids for bile-duct tissue engineering and disease modeling” (2023); Promoters: Prof. Dr. R. Masereeuw and Dr. B. Spee; Faculty of Sciences, Utrecht University-The Netherlands.
de Bruijn V.M.P.; "New approach methodologies (NAMs) to understand and predict drug-induced effects on bile acid homeostasis and cholestasis" (2024); Promoters: Prof. Dr. I.M.C.M. Rietjens and Dr. H. Bouwmeester; Wageningen University-The Netherlands.